Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 2,027.00
-53.00 (-2.55%)
At close: Dec 30, 2025
Genmab Market Cap
Genmab has a market cap or net worth of 124.86 billion as of December 31, 2025. Its market cap has increased by 25.88% in one year.
Market Cap
124.86B
Enterprise Value
104.05B
Revenue
24.48B
Ranking
n/a
PE Ratio
12.69
Stock Price
2,027.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 124.86B, an increase of 3,289.11%. That is a compound annual growth rate of 14.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 124.86B | 31.70% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.45T |
| Coloplast | 123.14B |
| ALK-Abelló | 50.56B |
| Demant | 45.84B |
| H. Lundbeck | 41.40B |
| Zealand Pharma | 32.85B |
| Ambu A/S | 23.42B |
| GN Store Nord | 15.54B |